Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.705 USD | +1.49% | +1.20% | -43.85% |
05-10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.85% | 43.55M | |
+42.27% | 748B | |
+33.89% | 598B | |
-5.74% | 356B | |
+18.63% | 325B | |
+4.90% | 283B | |
+17.53% | 245B | |
+9.25% | 211B | |
-4.21% | 209B | |
+3.10% | 166B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment